CAS 1229194-11-9

Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate (1:1:1)

Description:

Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate (1:1:1) is a complex organic compound characterized by its multi-functional structure, which includes an ethanediamide backbone and various substituents that contribute to its biological activity. The presence of a chloro group and a pyridine ring suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound also features a thiazole moiety, which is often associated with pharmacological properties. The sulfonate group enhances its solubility in aqueous environments, which is beneficial for biological applications. As a hydrate, it contains water molecules that can influence its stability and solubility. Overall, this compound's intricate structure and functional groups indicate potential utility in drug development, particularly in targeting specific biological pathways or receptors. Further studies would be necessary to elucidate its precise mechanisms of action and therapeutic potential.

Formula: C₂₄H₃₀ClN₇O₄S·C₇H₈O₃S·H₂O

InChI: InChI=1S/C24H30ClN7O4S.C7H8O3S.H2O/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23;1-6-2-4-7(5-3-6)11(8,9)10;/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34);2-5H,1H3,(H,8,9,10);1H2/t13-,15-,17+;;/m0../s1

InChI key: InChIKey=PSMMNJNZVZZNOI-SJILXJHISA-N

SMILES: N(C(=O)C1=NC2=C(S1)CN(C)CC2)[C@H]3[C@@H](NC(C(NC4=CC=C(Cl)C=N4)=O)=O)CC[C@H](C(N(C)C)=O)C3.S(=O)(=O)(O)C1=CC=C(C)C=C1.O

Synonyms:

• Edoxaban Tosylate Monohydrate
• Edoxaban tosylate hydrate
• Edoxaban4-methylbenzenesulfonate, hydrate (1:1:1)
• Ethanediamide, N¹-(5-chloro-2-pyridinyl)-N²-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate (1:1:1)
• N-(5-Chloropyridin-2-yl)-N′-((1S,2R,4S)-4-[(dimethyl amino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-toluenesulfonate monohydrate
• N-(5-Chloropyridin-2-yl)-N′-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide mono(p-toluenesulfonate) monohydrate
• Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate (1:1:1)
• Edoxaban tosylate monohydrate(for Edoxaban)

Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate (1:1:1)

CAS: 1229194-11-9

Formula: C₃₁H₄₀ClN₇O₈S₂

Purity: %

Color and Shape: Solid

Molecular weight: 738.2744

Ref: IN-DA000JRI

N1-(5-Chloropyridin-2-Yl)-N2-((1S,2R,4S)-4-(Dimethylcarbamoyl)-2-(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine-2-Carboxamido)Cyclohexyl)Oxalamide 4-Methylbenzenesulfonate Hydrate

CAS: 1229194-11-9

N1-(5-Chloropyridin-2-Yl)-N2-((1S,2R,4S)-4-(Dimethylcarbamoyl)-2-(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine-2-Carboxamido)Cyclohexyl)Oxalamide 4-Methylbenzenesulfonate Hydrate

Purity: 98%

Molecular weight: 738.27g/mol

Ref: 54-OR1025692

Edoxaban Tosylate Monohydrate

CAS: 1229194-11-9

Edoxaban Tosylate Monohydrate

Purity: ≥98%

Molecular weight: 738.27g/mol

Ref: 54-BUP13400

Edoxaban Tosylate Monohydrate

CAS: 1229194-11-9

Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention.

Formula: C₃₁H₄₀ClN₇O₈S₂

Purity: 99.86% - 99.91%

Color and Shape: Solid

Molecular weight: 738.27

Ref: TM-T2368

Edoxaban Tosylate Hydrate

CAS: 1229194-11-9

Formula: C₂₄H₃₀ClN₇O₄SC₇H₈O₃SH₂O

Molecular weight: 548.06 : 172.2 : 18.0

Ref: ST-EA-CP-E8017

Edoxaban Tosylate Monohydrate

CAS: 1229194-11-9

Applications Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor.
References Ruff, C., et al.: Am. Heart J., 160, 635 (2010); Ogata, K., et al.: J. Clin. Pharm., 50, 73 (2010)

Formula: C₃₁H₃₈ClN₇O₇S₂•xH₂O

Color and Shape: White To Off-White

Molecular weight: 720.26

Ref: TR-E555525

Edoxaban tosylate hydrate

CAS: 1229194-11-9

Edoxaban tosylate hydrate is an anticoagulant that inhibits the activity of thrombin and factor Xa. It has a long half-life and does not undergo significant first-pass metabolism in the liver. Edoxaban tosylate hydrate is used for the prevention of stroke in patients with atrial fibrillation. It can be administered orally or by intravenous infusion, and its effect is monitored by measuring levels of the natriuretic peptide NT-proBNP. Edoxaban tosylate hydrate has a low potential for drug interactions, which may be due to its low protein binding affinity (less than 10%). This drug also inhibits P-glycoprotein, which may lead to bleeding complications.

Formula: C₂₄H₃₀ClN₇O₄S·C₇H₈O₃S·H₂O

Purity: Min. 95%

Molecular weight: 738.28 g/mol

Ref: 3D-EZB19411